INVESTIGATING THE FITNESS BENEFIT OF REVERSE TRANSCRIPTASE (RT) MUTATION A62V CO-OCCURRING WITH M184V AND K65R IN HIV-1 SUBTYPE C Duncan T Njenda (MSc)

Slides:



Advertisements
Similar presentations
Emerging patterns of drug resistance and viral tropism in cART-naïve and failing patients infected with HIV-1 subtype C Thumbi Ndung’u, BVM, PhD Associate.
Advertisements

Supervisor: VS 高志平 Reporter: R4 張妙而.  Mutations in nucleophosmin 1 ( NPM1 ) gene, one of the most common gene mutations (25%-30%) in AML  NPM1 mut co-occurs.
Evolutionary Biology Group Isabel Gordo Genomes and Evolution.
6/28/00TPED1 Resistance Testing: What is it? What does it mean? How does drug resistance emerge? Overview of methods Advantages and disadvantages Current.
HIV dynamics in sequence space Shiwu Zhang Based on [Kamp2002from, Kamp2002co-evolution]
2 and 4 February, 2005 Chapter 7 Recombination in Bacteria and their Viruses Conjugation, transformation, transduction.
Undergraduate Research in Cancer Biology Mahima Venkatesh Mentor-Charmaine Ramlogan-Steel, MD (Postdoctoral Fellow) Principal Investigator- George Atweh,
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
HIV-1 DNA levels after antiretroviral therapy in primary infection predict disease progression: the SPARTAC Trial James Williams 1,2,3, Jacob Hurst 1,2,3,
Kristin Rosche, Emily Thornsen & Lloyd Turtinen  Department of Biology  University of Wisconsin-Eau Claire Knockout of the US29 gene of Human Cytomegalovirus.
Generation of Gateway clone library of virulence associated genes of zoonotic buffalopox virus: state-of-the-art resource for proteome analysis Veterinary.
Genome Structure of Retroviruses
Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Global HIV Resistance: The Implications of Transmission
HIV-1 evolution in response to immune selection pressures
Failure Therapy VIRAL RESITANCE ADHERENCE!!!!!!!!!!! DRUG INTERACTION.
Natural polymorphisms in the protease of HIV-1 isolates explain hypersusceptibility to protease inhibitors A.F. Santos, D.M. Tebit, M.S. Lalonde, A. Ratcliff,
1 Novel HIV Suppressive Approaches with Integrase Inhibitors Mark A Wainberg McGill University AIDS Centre Montreal, Canada.
Predicting NNRTI Resistance – do polymorphisms matter? Nicola E Mackie 1, Lucy Garvey 1, Anna Maria Geretti 2, Linda Harrison 3, Peter Tilston 4, Andrew.
1 ARV Drug Resistance HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Increased phenotypic susceptibility (hypersusceptibility, HS) to NNRTIs is observed in ~30% of viral isolates with NRTI- resistance mutations 1 and has.
Functional Integrals for the Parallel and Eigen Models of Virus Evolution Jeong-Man Park The Catholic University of Korea.
Phylodynamically Estimated HIV Diversification Rates Reveal Prevention of HIV-1 by Antiretroviral Therapy Jeffrey B. Joy, Richard H. Liang, Rosemary M.
Background Gregory Fischer Julie Anderson Daniel Herman  Department of Biology  University of Wisconsin-Eau Claire Heterologous expression of MBP1 from.
HIV-1 & HIV : Robert Gallo: HTLV-1/ lymphocytes 1978: Robert Gallo: HTLV-1/ lymphocytes of leukemia patients of leukemia patients HTLV :
HIV-1 Evolution and Drug Resistance Among Patients Receiving ART in San Mateo County, California, S. Dalai MSc, S. Sethi MSc, V. Levy MD, D.
High Discordance in Plasma and Genital Tract HIV-1 Drug Resistance in Indian Women Failing First-line Therapy MOPDA0106 S. Saravanan, PhD Session Code:
Virus, bacteria, and eukaryotic cell (Fig. 18.1).
46 th Interscience Conference on Antimicrobial Agents and Chemotherapy September , 2006 San Francisco, California Paper # H-1670 Resistance Mechanisms.
Recombinant DNA What is the basis of recombinant DNA technology? How does one “clone” a gene? How are genetically modified organisms (GMOs) created? Illustration.
Infection and Disease Fungi Parasites Nosocomial infection Diagnosis of infectious disease.
Washington D.C., USA, July 2012www.aids2012.org Changing Patterns of NRTI and PI Resistance Mutations Between 2006 and 2011 in ART experienced SA.
ProteinStart position HLAEpitopePositive responses (n) Env209A*0101SFEPIPSHY1 Env310A*0101/Cw*0401GPGPGRAFY1 Gag406A*0302RAPRKKGC WK 1 Nef9A*0101/A*0302SVVGWPAVR1.
Management of NRTI Resistance
Virology 1.5-Genetics Some terminology from the last part of Chapter 3.
Taylor Bendt Faculty advisor: Dr. Gary Merrill. DNA Damage p53 DNA repairApoptosisp21 Cell cycle arrest Genome maintenance  Important for cancer prevention.
Tumor Suppressors Versus Oncogenes. Retinoblastoma is a Cancerous Disease Hereditary childhood cancer: bilateral tumors in 25-30% of cases unilateral.
ICASA Track A – Basic Science Rapporteur’s Report.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
“Neutralizing Antibodies Derived from the B Cells of 1918 Influenza Pandemic Survivors” (Yu et. al) Daniel Greenberg.
Relationship Between STAT3 Inhibition and the Presence of p53 on Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines Introduction STAT3 and p53.
Gene Cloning & Creating DNA Libraries. Клонирование генов Что означает термин «клонирование»? Как происходит клонирование генов? Чем это отличается от.
Kalyan Das CABM & Rutgers University, NJ, USA
Dawit Assefa Ethiopia Health and Nutrition Research Institute Dawit Assefa Ethiopia Health and Nutrition Research Institute Evaluation of an in-house HIV.
Novel assay using PCR and mass spectrometry for quantification of minor populations of HIV-1 carrying drug-resistant mutations Kato Shingo, Koji Sudo,
HIV Drug Resistance Surveillance Satellite Session: HIV Drug Resistance Surveillance and Control: a Global Concern Silvia Bertagnolio, MD WHO,
High prevalence of antiretroviral drug resistance among HIV-infected pregnant women in Buenos Aires, Argentina Zapiola 1, D.M. Cecchini 2, S. Fernandez.
A HIGHER FRACTION OF DRUG RESISTANT PROVIRUSES EXPRESS UNSPLICED HIV RNA DURING ART COMPARED TO THE ARCHIVAL WILD-TYPE PROVIRUSES THAT COMPRISE THE HIV-1.
Phylogenetic relationships of HIV-1 Pol RT strains
Effects of Self-Targeting and Cargo Orientation on Efficient Delivery of Anti-HIV-1 RT RNA Aptamer Cargo By a Lentiviral Vector Margaret J. Lange1,2, Carolina.
Prevalence and clinical implications of NRTI- and NNRTI-associated minority variant drug-resistance mutations in ARV-naïve patients with and without transmitted.
Volume 65, Issue 1, Pages S2-S21 (October 2016)
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort.
Introduction Results Objectives Methods Conclusion Funding
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface
Disruption of the BGLF2 gene decreased infectious progeny production.
Alvaro San Millan  Trends in Microbiology 
Volume 65, Issue 1, Pages (January 2017)
Trans-Splicing to Spliceosomal U2 snRNA Suggests Disruption of Branch Site-U2 Pairing during Pre-mRNA Splicing  Duncan J. Smith, Charles C. Query, Maria.
Volume 20, Issue 3, Pages (September 2016)
Volume 13, Issue 9, Pages (December 2015)
Introduction The Future.
Analysis of PHO1 Expression by RT-qPCR in the pru1 Mutant, Complementation Lines (COM5 and COM7), and Wild-type Plants during Pi Starvation. Analysis of.
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner  Juan Lama, Aram Mangasarian,
by Brett D. Anderson, and Reuben S. Harris
HIV-1 Vif Adaptation to Human APOBEC3H Haplotypes
Rapid Detection of HIV-1 subtype C Integrase resistance mutations by the Use of High-Resolution Melting Analysis Tendai Washaya BSc, Msc. Pre-PhD Student.
HVDRS STUDY RESISTANCE: WE CARE
Presentation transcript:

INVESTIGATING THE FITNESS BENEFIT OF REVERSE TRANSCRIPTASE (RT) MUTATION A62V CO-OCCURRING WITH M184V AND K65R IN HIV-1 SUBTYPE C Duncan T Njenda (MSc) Division of Medical Virology Supervisor: Professor G. U. Van Zyl Co-supervisor: Professor S. Engelbrecht Co-supervisor: Dr G. B. Jacobs

OVERVIEW * HIV-1 viral evolutionary dynamics * Preliminary data * Research hypothesis, Aims and objectives * Methodology * Results * Discussion * Conclusion and recommendations * Acknowledgements

HIV viral evolutionary Dynamics Host immune response Latency- Archived resistance virus Recombination Drug resistant virus (DRV) carrying Drug resistant mutation (DRM) Viral fitness?? ???

HIV Drug resistance Classification DRM Acquired DRMs Major (Primary) Resistance Discriminatory mutations e.g. K65R, M184V, Q151M Primer Unblocking mutations e.g. TAMs I & II Secondary resistance Accessory mutations Compensatory mutations Transmitted resistance MTCT -Heterosexual transmission

Preliminary Data Tygerberg Hospital HIV-1 cohort on TDF/3TC or FTC/EFV or NVP ----> 164 patients A62V co-occurs significantly more (p <0.01, fisher exact test) with M184V and K65R

Research hypothesis & objectives Research hypothesis * The A62V mutation is selected as a compensatory mutation to restore viral fitness in patients harboring the K65R and M184V reverse transcriptase mutations. Study aim: * to investigate the relative fitness interaction of A62V when co- occurring with K65R and M184V in HIV-1 subtype C Objectives: Synthesis of A62V; M184V,K65R, A62V+M184V; K65R+ M184V;A62V+ K65R and A62V+K65R+M184V full length genome (FLG) plasmid constructs harbouring these mutations Testing the relative fitness of A62V+K65R+M184V vs M184V+K65R clones in a head to head in-house allele-specific qPCR based growth competition assay.

Methodology Plasmid Extraction NL4.3 eGFP derived vector MJ4_HIV-1C pol gene Mutated construct

Schematic of Plasmid map Plasmid constructs (n=8) 62V+65R+184V 62V Wild type 184V 65R 62V + 65R 62V +184V 65R+184V

Mutant Constructs Transfect 293T cells to generate viral stocks Inoculate virus in TZM- bl cells grown in 6 well culture plates flask harvest every 0, 48,72 hrs Overall workflow for Growth experiment setup

Allele-specific qPCR experiment setup

Results - Growth curves

Results - Statistical analysis

A62V mutation does not have a significant effect on viral fitness when it co-occurs with M184V and K65R. Unexpected! Previous work suggested A62V restored fitness loss conferred by K65R in the presence of S68G (Svarovskaia et al., 2008) A62V restored fitness when it occurred in concert with Q151M, F116Y, F77L and V75L mutations (Maeda et al., 1998). Stanford HIVDB indicates A62V as a resistance mutation - but no peer reviewed publication that provides evidence of the effect of A62V on TDF resistance?? Lit. suggests secondary mutations would contribute to higher levels of TDF resistance or fitness compensation. Discussion

A62V reverse transcriptase mutation in HIV-1 has no significant fitness compensation effect when it co-occurs with M184V and K65R Further investigations would be required to investigate the fitness effect of individual mutations and all the possible mutation interactions Emphasis on patient monitoring and resistance testing Conclusion and Recommendations

ACKNOWLEDGEMENTS I am grateful and thankful to: * Professor G.U. van Zyl * Professor S. Engelbrecht * Dr G.B. Jacobs * Students and Staff of the Division of Medical Virology, Stellenbosch University I am grateful and thankful to the following Organisations for Funding:  Poliomyelitis Research Foundation (PRF)  Harry Crossley Foundation